A clinical trial on MUSUMUSKKAI KUDINEER in the management of PITHA PAANDU (IRON DEFICIENCY ANAEMIA)
Phase 2
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2022/02/040037
- Lead Sponsor
- Government Siddha Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Hb level above 7.0 grams - below 10 grams
2.Patient with the symptoms of Pallor of skin, Mucous membrane, Conjunctiva, Nail beds. Fatigue, shortness of breath, palpitation. Worm infestations. Blood loss due to Menstrual disorders, Hemorrhoids, and Peptic ulcer
3.Clinically diagnosis in Iron Deficiency Anaemia, smear showing hypochromic microcytic anaemia
Exclusion Criteria
1.Hb levels below 7.0 grams and above 10 grams
2.Congenital heart diseases
3.Patients with chronic renal diseases
4.Liver diseases
5.Inherited hemolytic defects
6.Thalassemia
7.Thyroid disorder
8.Diabetes mellitus
9.Pregnancy and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the therapeutic efficacy of clinical trial drug in management of Pitha PaanduTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method 1.To evaluate the biochemical physico-chemical and phytochemical analysis of clinical trial drug <br/ ><br>2.To evaluate the antimicrobial activity of trial drug <br/ ><br>3.To evaluate the safety profile for acute and subacute toxicity of the trial drug musumuskkai kudineer <br/ ><br>4.To evaluate pharmacological analysis of the clinical trial drug <br/ ><br>5.To evaluate Siddha parameters and modern parameters during the treatment of Pitha Paandu with trial drug <br/ ><br>6.To evaluate the statistical analysis of the clinical trial drug musumuskkai kudineerTimepoint: 45 days